Fluorescence Immunity Fertility Test (FIFT) is a diagnostic test used to assess the fertility potential in both men and women. The test measures the levels of fertility-related hormones and biomarkers, such as follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), and anti-Mullerian hormone (AMH). The test is performed by analyzing a small blood sample in a laboratory using fluorescence microscopy and immunohistochemistry. The results of the FIFT can be used to diagnose fertility problems in both men and women, allowing for prompt medical intervention and treatment. The FIFT is non-invasive, quick, and has a high degree of sensitivity and specificity, making it a valuable diagnostic tool for infertility assessment.
The purpose of Fluorescence Immunity Fertility Test (FIFT) is to assess fertility potential in women. By measuring the level of fertility-related hormones and biomarkers, FIFT can diagnose infertility issues and predict ovarian reserve. The test is used to help couples determine their chances of conceiving naturally, or decide on the appropriate course of medical intervention for fertility issues.
While Fluorescence Immunity Fertility Test (FIFT) is primarily used to assess fertility potential in women, it can also provide some information about male fertility. However, other tests are typically used to specifically assess male fertility. The FIFT primarily focuses on predicting ovarian reserve and detecting female infertility issues.